Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-02

FDA Approved: NINTEDANIB — Original Application (Edenbridge Pharmaceuticals LLC.)

View source ↗

Summary

FDA approved the original application for a generic version of nintedanib, developed by Edenbridge Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nintedanib (nintedanib)

Snippet

ORIG AP for NINTEDANIB (NINTEDANIB)